Status:

COMPLETED

Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft

Lead Sponsor:

AlloSource

Conditions:

Degenerative Osteoarthritis

Post-traumatic; Arthrosis

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The purpose of this clinical trial is to evaluate the outcome of implanting AlloStem® graft with appropriate rigid internal fixation hardware as an alternative to autograft bone graft with rigid fixat...

Eligibility Criteria

Inclusion

  • Must be diagnosed with degenerative osteoarthritis, post-traumatic arthritis, inflammatory arthritis (ie: rheumatoid arthritis) or other conditions of the hindfoot requiring subtalar arthrodesis.
  • Patients must be able to attend follow-up examinations for the duration of the trial.
  • The patient is at least 18 years of age and skeletally mature, or less than 80 years of age at the time of surgery.
  • Is willing and able to comply with the clinical trial plan and able to understand and sign the Patient Informed Consent Form.

Exclusion

  • Younger than 18 years old or older than 80 years old.
  • Has a condition that prevents ambulation or completion of any of the trial measurements.
  • Requires fusion of additional hindfoot or ankle joints simultaneously (i.e. a pantalar, tibiotalocalcaneal or triple arthrodesis). Concomitant midfoot or forefoot procedures, such as osteotomies, tendon or metatarsal procedures are not exclusionary.
  • Has treatment planned for the arthrodesis which does not require the use of screws.
  • Has any active infection of the hindfoot, a systemic infection or bacteremia.
  • Has received any treatment within the past 12 months which may interfere with bone metabolism \[bisphosphonates (Fosamax, Actonel, Boniva, Reclast) and calcitonin (Miacalcin)\].
  • Is scheduled to have any surgical procedure on the contralateral foot within 6 weeks before or after the study procedure.

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2018

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT01413061

Start Date

June 1 2010

End Date

March 1 2018

Last Update

April 13 2018

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Institute for Foot and Ankle Reconstruction at Mercy

Baltimore, Maryland, United States, 21202

2

Orthopaedic Associates of Michigan

Grand Rapids, Michigan, United States, 49525

3

Minnesota Orthopedic Sports Medicine Institute (MOSMI)

Edina, Minnesota, United States, 55435

4

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States, 17033